AMEX HALT ADDITIONAL INFORMATION LAST 1.69000
AMEX RESUMED BIOMX INC UNT
AMEX HALT ADDITIONAL INFORMATION LAST 1.99000
AMEX RESUMED BIOMX INC UNT
AMEX HALT ADDITIONAL INFORMATION LAST 1.58000
AMEX RESUMED BIOMX INC UNT
AMEX HALT ADDITIONAL INFORMATION LAST 1.67000
Brief: Biomx Inc Announces Voluntary Delisting From Tel Aviv Stock Exchange
Brief: Boehringer Ingelheim And Biomx Collaborate To Discover Inflammatory Bowel Disease Microbiome Biomarkers
Brief: Biomx Announces Dosing Of The First Two Patients In Phase 1B/2A Study Of Bx004 For Treatment Of Chronic Respiratory Infections In Patients With Cystic Fibrosis
U.S. STOCKS ON THE MOVE-Snap, Abercrombie & Fitch, Genocea Biosciences
Biomx Inc rallies on plan to cut headcount by 50%
Brief: Biomx Says Reducing Headcount By 50% To Further Extend Capital Resources
Brief: Biomx Reports First Quarter 2022 Financial Results And Provides Business Update
Brief: Biomx Reports Q4 Results
Brief: Biomx Reports Quarterly Loss Per Share Of Common Stock $0.37
AMEX RESUMED BIOMX INC UNT
AMEX HALT ADDITIONAL INFORMATION LAST 4.48010
AMEX RESUMED BIOMX INC UNT